Novotech Featured Reports
-
Accelerating Trial Start-Up: CRO Best Practices For 2025
7/8/2025
In 2025, accelerating clinical trial start-up is critical, and Clinical Research Organizations (CROs) are applying innovative approaches to drive efficiency in site activation, enrollment, and regulatory approvals.
-
What ASCO 2025 Means For The Future Of Oncology Trials
6/13/2025
Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.
-
Top Biotech Hubs Around The World: Where Innovation Thrives In 2025
5/20/2025
Explore the leading biotech hubs in 2025, what makes them unique, and how companies can leverage these ecosystems to accelerate innovation and growth.
-
Overview Of Obesity: Global Clinical Trials Landscape
5/20/2025
This comprehensive overview of current and emerging obesity treatments provides insight into the growing global health crisis that is rising in prevalence across all demographics and income levels.
-
How Clinical Trials Work
4/4/2025
Explore a comprehensive overview of clinical trial designs and protocols; including the four distinct phases, eligibility criteria, and essential methodologies.
-
Bladder Cancer: Challenges And Innovations
4/4/2025
Bladder cancer ranks ninth in incidence and 13th in mortality among cancers. Recent advancements in treatment are transforming the management of advanced bladder cancer cases.
-
Regulatory Compliance In Clinical Research
3/28/2025
Understand the critical aspects of regulatory compliance, and gain insights into how you can safeguard participant rights and ensuring the integrity of clinical research.
-
How To Choose The Right CRO For Your Clinical Trial
3/28/2025
Selecting the right Contract Research Organization (CRO) is critical for the success of a clinical trial. This article outlines essential factors to consider during the selection process.
-
Why Biotechs Should Leverage Australia's Clinical Research Ecosystem
3/28/2025
With a proven track record across diverse therapeutic areas, Australia is a cost-effective option as well as a strategic ally for biotech firms.
-
The "Unique" Opportunity Presented by Southeast Asia
2/26/2025
Southeast Asia has emerged as a pivotal region for vaccine clinical trials, driven by rapid recruitment, cost efficiency, and robust immunization infrastructure.